Q&As in 2019

Filter By:

Article Type
Year
  • Dave Laffan, a Director in Chemical Development at AstraZeneca, talks to Nature Chemistry about safety in industry labs and his role on the Safety, Health and Environment committee.

    • Katherine Geogheghan
    Q&A
  • Marc Reid, a researcher at the University of Strathclyde and co-founder of Pre-Site Safety, talks to Nature Chemistry about safety, both as an academic scientist and as a director of a safety-focused company.

    • Katherine Geogheghan
    Q&A
  • Jadambaa Khuyagbaatar from the Helmholtz Institute Mainz and the GSI Helmholtz Centre for Heavy Ion Research talks to Nature Chemistry about superheavy element studies and why creating and exploring these fleeting nuclei matters.

    • Anne Pichon
    Q&A